J&J Medical Connect
Oncology
Oncology

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

Summary

MM is when plasma cells become malignant and secrete monoclonal proteins1

MM is more common in men, Black individuals, and older individuals (median age of diagnosis is 69 years)2

MM is a clonally heterogenous disease that contributes to treatment resistance and relapse3

High attrition rates underscore the need to use the most optimal treatment regimens upfront rather than reserving them for later LOTs4

With the therapeutic improvement observed in the past few years, achievement of an operational cure is increasingly becoming a realistic goal5


MM, multiple myeloma.

1. American Cancer Society. What is multiple myeloma? Accessed February 20, 2026. https://www.cancer.org/cancer/multiple-myeloma/about/what-is-multiple-myeloma.html. 2. SEER Cancer stat facts: Myeloma. National Cancer Institute. Bethesda, MD. Accessed February 20, 2026. http://seer.cancer.gov/statfacts/html/mulmy.html. 3. Bolli N, et al. Nat Commun. 2014;5:2997. 4. Fonseca R, et al. BMC Cancer. 2020;20(1):1087. 5. Mohty M, et al. Blood. 2021;138(16):1406-1411.

Would you like to clear and leave your conversation? Message history will be lost.